305 related articles for article (PubMed ID: 21825246)
21. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
Iwanami M; Odaka M; Nakamura T; Hirata K
Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
[TBL] [Abstract][Full Text] [Related]
22. Paraneoplastic cerebellar degeneration associated with serous adenocarcinoma of the ovary.
Saeed DB; Gupta L
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25432905
[TBL] [Abstract][Full Text] [Related]
23. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
Cao Y; Abbas J; Wu X; Dooley J; van Amburg AL
Gynecol Oncol; 1999 Oct; 75(1):178-83. PubMed ID: 10502450
[TBL] [Abstract][Full Text] [Related]
24. [Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies in ovarian carcinoma].
Holzmann P; Holy D; Stillhard G; Janda M; Möbr P
Schweiz Med Wochenschr; 1998 Jun; 128(23):906-8. PubMed ID: 9658519
[TBL] [Abstract][Full Text] [Related]
25. [Paraneoplastic cerebellar degeneration associated with anti-Ma2 antibodies].
Ameneiros-Lago E; Fernández-Fernández FJ; Lijó-Carballeda C
Med Clin (Barc); 2016 Nov; 147(10):e55-e56. PubMed ID: 27650210
[No Abstract] [Full Text] [Related]
26. TRIM9 and TRIM67 Are New Targets in Paraneoplastic Cerebellar Degeneration.
Do LD; Gupton SL; Tanji K; Bastien J; Brugière S; Couté Y; Quadrio I; Rogemond V; Fabien N; Desestret V; Honnorat J
Cerebellum; 2019 Apr; 18(2):245-254. PubMed ID: 30350014
[TBL] [Abstract][Full Text] [Related]
27. Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique.
Monstad SE; Storstein A; Dørum A; Knudsen A; Lønning PE; Salvesen HB; Aarseth JH; Vedeler CA
Clin Exp Immunol; 2006 Apr; 144(1):53-8. PubMed ID: 16542365
[TBL] [Abstract][Full Text] [Related]
28. [Paraneoplastic cerebellar degeneration. A case report].
Storstein A; Vedeler C; Krossnes B; Mørk S
Tidsskr Nor Laegeforen; 1997 Aug; 117(20):2947-8. PubMed ID: 9340852
[TBL] [Abstract][Full Text] [Related]
29. Cerebellar degeneration associated with mGluR1 autoantibodies as a paraneoplastic manifestation of prostate adenocarcinoma.
Iorio R; Damato V; Mirabella M; Vita MG; Hulsenboom E; Plantone D; Bizzarro A; Del Grande A; Sillevis Smitt PA
J Neuroimmunol; 2013 Oct; 263(1-2):155-8. PubMed ID: 23958353
[TBL] [Abstract][Full Text] [Related]
30. Probably anti-Tr associated paraneoplastic cerebellar degeneration as initial presentation of a squamous cell carcinoma of the lung.
Bruylant K; Crols R; Humbel RL; Appel B; De Deyn PP
Clin Neurol Neurosurg; 2006 Jun; 108(4):415-7. PubMed ID: 16644410
[TBL] [Abstract][Full Text] [Related]
31. Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study.
Brieva-Ruíz L; Diaz-Hurtado M; Matias-Guiu X; Márquez-Medina D; Tarragona J; Graus F
Clin Neurol Neurosurg; 2008 Dec; 110(10):1044-6. PubMed ID: 18701208
[TBL] [Abstract][Full Text] [Related]
32. Paraneoplastic cerebellar degeneration with fallopian tube adenocarcinoma.
Tanaka Y; Suzuki N; Takao M; Ichikawa A; Susumu N; Aoki D
Gynecol Oncol; 2005 Nov; 99(2):500-3. PubMed ID: 16126258
[TBL] [Abstract][Full Text] [Related]
33. [Autoimmune paraneoplastic cerebellar degeneration].
Lövblad KO; Henny C; Boucraut J; Graus F; Delaloye JF; Bernard D; Steck AJ; Regli F
Rev Neurol (Paris); 1994; 150(1):46-9. PubMed ID: 7801040
[TBL] [Abstract][Full Text] [Related]
34. [Paraneoplastic cerebellar degeneration as initial presentation of a pancreatic small-cell carcinoma].
Salmerón-Ato P; Medrano V; Morales-Ortiz A; Martínez-García FA; Villaverde-González R; Bas A; Fernández-Barreiro A; Moltó-Jordà JM
Rev Neurol; 2002 Dec 16-31; 35(12):1112-5. PubMed ID: 12497294
[TBL] [Abstract][Full Text] [Related]
35. A case report of plasmapheresis treatment in a patient with paraneoplastic cerebellar degeneration and high anti-yo antibody titers.
Landtblom AM; Lindvall B; Ledin T; Berlin G
Ther Apher Dial; 2008 Feb; 12(1):82-5. PubMed ID: 18257818
[TBL] [Abstract][Full Text] [Related]
36. Two paraneoplastic syndromes in a patient with ovarian cancer: nephrotic syndrome and paraneoplastic cerebellar degeneration.
Forgy AP; Ewing TL; Flaningam J
Gynecol Oncol; 2001 Jan; 80(1):96-8. PubMed ID: 11136578
[TBL] [Abstract][Full Text] [Related]
37. [Paraneoplastic cerebellar degeneration with bladder cancer confirmed the existence of an anti-neural antibody: a case report].
Kawanishi K; Morita M; Nakahara K; Tetsuka S; Kouki T; Tominaga K; Endo H; Yashiro T; Tanaka K; Nakano I
Brain Nerve; 2013 Nov; 65(11):1401-5. PubMed ID: 24200618
[TBL] [Abstract][Full Text] [Related]
38. Expression of Yo Antigen in a Prostatic Adenocarcinoma.
Rosine N; Chrétien P; Adam C; Beaudonnet G; Not A; Drai J; Vahedi K; Cauquil C; Theaudin M
Can J Neurol Sci; 2017 Mar; 44(2):221-223. PubMed ID: 28231864
[No Abstract] [Full Text] [Related]
39. Paraneoplastic cerebellar syndromes associated with antibodies against Purkinje cells.
Schwenkenbecher P; Chacko L; Pul R; Sühs KW; Wegner F; Wurster U; Stangel M; Skripuletz T
Int J Neurosci; 2018 Aug; 128(8):721-728. PubMed ID: 29199513
[TBL] [Abstract][Full Text] [Related]
40. ZIC antibodies in paraneoplastic cerebellar degeneration and small cell lung cancer.
Sabater L; Bataller L; Suárez-Calvet M; Saiz A; Dalmau J; Graus F
J Neuroimmunol; 2008 Sep; 201-202():163-5. PubMed ID: 18639938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
